Who is COVID-19 hitting the hardest?
By: Pooja Dasgupta and Sonya Wadhawan, PharmD Candidates c/o 2025 The coronavirus, also known as SARS CoV-2 or COVID-19,…
The Cardiovascular Effects of Cannabis vs. Tobacco Consumption
By: Jeng Lee, PharmD Candidate c/o 2022 Throughout the past decade, there has been an increase in the prevalence…
New Drug Update: Lemborexant (Dayvigo ®)
By: Cindy Van, PharmD Candidate c/o 2022, Shireen Farzadeh, PharmD, BCPS Insomnia is a condition characterized by difficulty falling…
Rybelsus: Novel Oral GLP-1 Agonist and the Future of Oral Protein Dosage Forms
By: Tanay Maddula PharmD Candidate c/o 2022 Rybelsus (oral semaglutide) was recently approved by the Food and Drug Administration…
Fostemsavir: New drug for the treatment of HIV-1 resistant patients
By: Bisma Sekhery, PharmD Candidate c/o 2021 Fostemsavir (Rukobia) is a new Food and Drug Administration (FDA) approved antiretroviral…
Emerging Type 3 Diabetes
By: Zarnab Jillani PharmD Candidate c/o 2022 The link between diabetes and Alzheimer’s disease (AD) is a new and…
Increasing Evidence of the Benefits of Statins
By: Pallak Sharma, PharmD Candidate c/o 2022 and Rebecca Samuel, PharmD Candidate c/o 2022 Statins, some of the most…
AstraZeneca Sells Rights to Two Cardiovascular Drugs for $400 Million
By: Jennifer Galvet, PharmD Candidate c/o 2024 Introduction The British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has agreed to sell…
Flu Shot Season, COVID-19 and How Pharmacies are Bracing for Impact
By: Rebecca Samuel, PharmD Candidate c/o 2022 and Pallak Sharma, PharmD Candidate c/o 2022 It is flu shot season!…
Use of dexamethasone for the treatment of COVID-19: an update
By: Bisma T. Sekhery PharmD. Candidate c/o 2025 COVID-19 has had a significant impact on the health, economic, and…